OraSure Technologies completes acquisition of Sherlock Biosciences, Inc. to expand its innovation pipeline in molecular testing market
Acquiring Company
OraSure Technologies
Acquired Company
Sherlock Biosciences
BethlehemBostonBiotechnologyHealth CareMedicalHealth DiagnosticsBiotechnologyHealthcareData And AnalyticsHealth CareScience And EngineeringDescription
OraSure Technologies, Inc. has announced the acquisition of Sherlock Biosciences, Inc. This strategic acquisition expands OraSure’s innovation pipeline with the addition of Sherlock’s molecular diagnostics platform, aiming to deliver lab-like accuracy in a format that expands access to diagnostic insights through convenient, effortless tests and further increases its presence in the $1.5B molecular testing market.
Quick answer
OraSure Technologies is acquiring Sherlock Biosciences, announced December 19, 2024. OraSure Technologies is based in Bethlehem, Pennsylvania, United States.
- How much did OraSure Technologies pay for Sherlock Biosciences?
- The deal value was not disclosed.
- What does OraSure Technologies do?
- OraSure Technologies (the “Company”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are.
- Where are OraSure Technologies and Sherlock Biosciences based?
- OraSure Technologies is based in Bethlehem, Pennsylvania, United States. Sherlock Biosciences is based in Boston, Massachusetts, United States.
- Who are the decision-makers at OraSure Technologies?
- Fundz holds 1 contact at OraSure Technologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Vivo Infusion completes acquisition of Neurology Institute of San Antonio and Vista Infusions to expand infusion services (January 9, 2025)
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Eton Pharmaceuticals completes acquisition of Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. to advance treatment for Wilson Disease (January 5, 2025)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
Who to call at OraSure Technologies, and when
When OraSure Technologies changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day OraSure Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OraSure Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OraSure Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OraSure Technologies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sherlock Biosciences?
Sherlock Biosciences was acquired by OraSure Technologies, based in Bethlehem. The deal was reported on December 19, 2024. OraSure Technologies (the “Company”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure Technologies is publicly traded (OSUR) and operates in Biotechnology.
When did OraSure Technologies acquire Sherlock Biosciences?
OraSure Technologies's acquisition of Sherlock Biosciences was reported on December 19, 2024. OraSure Technologies, Inc. has announced the acquisition of Sherlock Biosciences, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sherlock Biosciences do?
Sherlock Biosciences is developing products that will empower people to access answers and have more control over their health decisions. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.